Clinical Trial Update: Single-arm, Prospective Study of the Efficacy and Safety of Paiteling®Antibacterial Liquid in the Treatment of Persistent Cervical HR-HPV Infection [Phase 4]

View source ↗

Summary

Phase 4 prospective, single-arm study evaluating the efficacy and safety of Paiteling Antibacterial Liquid for persistent cervical high-risk HPV infection; curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Persistent Cervical High-risk Human Papillomavirus Infection

Drugs mentioned

• Paiteling Antibacterial Liquid

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: Persistent HR-HPV Infection of the Cervix | Phase 4 | Status: RECRUITING